Thomas A. D'Amico, MD

AddThis

Print

email this


Professor of Surgery
Chief, Section of General Thoracic Surgery, Vice Chair of Surgery, Chief Medical Officer of Duke Cancer Institute
Department / Division:
Surgery / Cardiovascular & Thoracic
Address:
DUMC 3496
Duke South Rooms 3589
Durham, NC 27710
Appointment Telephone:
919-684-4891
Office Telephone:
919-684-4891
Fax:
919-684-8508
Training:
  • MD, Columbia University College of Physicians and Surgeons (New York), 1987
Residency:
  • Thoracic Surgery, Duke University Medical Center, 1987-1996
Fellowship:
  • Thoracic Oncology, Memorial Sloan-Kettering Cancer Center, 1996
Clinical Interests:
Lung and esophageal cancer; general thoracic and thorocoscopic surgery; minimally invasive thoracic surgery; thoracic oncology; lung volume reduction; photodynamic therapy (PDT); laser bronchoscopy; bronchial and esophageal stents; molecular biology of lung and esophageal cancer
Representative Publications:
  • Joshi, MB; D'Amico, TA; Harpole, DH. Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue. Methods in Molecular Medicine. 2003;75:369-388.  Abstract
  • D'Amico, TA. Molecular biologic substaging of non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 2002;123:409-410.  Abstract
  • D'Amico, TA; Wong, TZ; Harpole, DH; Brown, SD; Coleman, RE. Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. Annals of Thoracic Surgery. 2002;74:160-163.  Abstract
  • Daniels, LJ; Balderson, SS; Onaitis, MW; D'Amico, TA. Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Annals of Thoracic Surgery. 2002;74:860-864.  Abstract
  • Lau, CL; Moore, MB; Brooks, KR; D'Amico, TA; Harpole, DH. Molecular staging of lung and esophageal cancer. Surgical Clinics of North America. 2002;82:497-523.  Abstract
  • Aloia, TA; Harpole, DH; Reed, CE; Allegra, C; Moore, MB; Herndon, JE; D'Amico, TA. Tumor marker expression is predictive of survival in patients with esophageal cancer. Annals of Thoracic Surgery. 2001;72:859-866.  Abstract
  • D'Amico, TA; Aloia, TA; Moore, MB; Conlon, DH; Herndon, JE; Kinch, MS; Harpole, DH. Predicting the sites of metastases from lung cancer using molecular biologic markers. Annals of Thoracic Surgery. 2001;72:1144-1148.  Abstract
  • Harpole, DH; Moore, MB; Herndon, JE; Aloia, T; D'Amico, TA; Sporn, T; Parr, A; Linoila, I; Allegra, C. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clinical Cancer Research. 2001;7:562-569.  Abstract
  • Markert, ML; Alvarez-McLeod, AP; Sempowski, GD; Hale, LP; Horvatinovich, JM; Weinhold, KJ; Bartlett, JA; D'Amico, TA; Haynes, BF. Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Research and Human Retroviruses. 2001;17:1635-1643.  Abstract
  • D'Amico, TA; Aloia, TA; Moore, MB; Herndon, JE; Brooks, KR; Lau, CL; Harpole, DH. Molecular biologic substaging of stage I lung cancer according to gender and histology. Annals of Thoracic Surgery. 2000;69:882-886.  Abstract
  • D'Amico, TA; Harpole, DH. Molecular biology of esophageal cancer. Chest Surgery Clinics of North America. 2000;10:451-469.  Abstract
  • Lau, CL; Palmer, SM; Posther, KE; Howell, DN; Reinsmoen, NL; Massey, HT; Tapson, VF; Jaggers, JJ; D'Amico, TA; Davis, RD. Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Annals of Thoracic Surgery. 2000;69:1520-1524.  Abstract
  • Morse, MA; Bossen, E; D'Amico, TA; Williamson, W; Johnson, R. Myxoid liposarcoma of the supraclavicular fossa. Chest. 2000;117:1518-1520.  Abstract
  • Shah, AS; Forbess, JM; Skaryak, LA; Lilly, RE; Vaslef, SN; D'Amico, TA. Emergent thoracotomy for airway control after intrathoracic tracheal injury. Journal of Trauma: Injury Infection and Critical Care. 2000;48:1163-1164.  Abstract
  • D'Amico, TA; Massey, M; Herndon, JE; Moore, MB; Harpole, DH. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. Journal of Thoracic and Cardiovascular Surgery. 1999;117:736-743.  Abstract